[go: up one dir, main page]

AR047707A1 - Un procedimiento de sintesis de compuestos de la 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable - Google Patents

Un procedimiento de sintesis de compuestos de la 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable

Info

Publication number
AR047707A1
AR047707A1 ARP050100586A ARP050100586A AR047707A1 AR 047707 A1 AR047707 A1 AR 047707A1 AR P050100586 A ARP050100586 A AR P050100586A AR P050100586 A ARP050100586 A AR P050100586A AR 047707 A1 AR047707 A1 AR 047707A1
Authority
AR
Argentina
Prior art keywords
synthesis
formula
ivabradine
compounds
procedure
Prior art date
Application number
ARP050100586A
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Jean-Claude Souvie
Daniel Brigot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR047707A1 publication Critical patent/AR047707A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de formula (2), donde R1 y R2, idénticos o diferentes, representan cada uno un grupo alcoxi C1-8 lineal o ramificado, o forman conjuntamente con el átomo de carbono que los lleva un anillo 1,3-dioxano, 1,3-dioxolano o 1,3- dioxepano. Reivindicacion 1: Procedimiento de síntesis de compuestos formula (1), donde R1 y R2, idénticos o diferentes, representan cada uno un grupo alcoxi C1-8 lineal o ramificado, o bien forman conjuntamente con el átomo de carbono que los lleva un anillo 1,3-dioxano, 1,3-dioxolano o 1,3-dioxepano, caracterizado porque se somete el compuesto de formula (2), donde R1 y R2 son tales como se definiera precedentemente, a una reaccion de hidrogenacion catalítica, en un solvente no acídico, luego se filtra la mezcla de reaccion, para obtener el compuesto de formula (1). Reivindicacion 11: Procedimiento de síntesis de la ivabradina y de sus sales farmacéuticamente aceptables e hidratos, caracterizado porque el compuesto de formula (2) se convierte en el compuesto intermediario de formula (1) de acuerdo con el procedimiento de la reivindicacion 1, y luego el compuesto intermediario de formula (1) se convierte en ivabradina.
ARP050100586A 2004-04-13 2005-02-18 Un procedimiento de sintesis de compuestos de la 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable AR047707A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403828A FR2868775B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
AR047707A1 true AR047707A1 (es) 2006-02-08

Family

ID=34941961

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100586A AR047707A1 (es) 2004-04-13 2005-02-18 Un procedimiento de sintesis de compuestos de la 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable

Country Status (32)

Country Link
US (1) US7064200B2 (es)
EP (1) EP1614687B1 (es)
JP (2) JP4515933B2 (es)
KR (1) KR100636499B1 (es)
CN (1) CN100348585C (es)
AR (1) AR047707A1 (es)
AT (1) ATE448221T1 (es)
AU (1) AU2005200884B2 (es)
BR (1) BRPI0500590B8 (es)
CA (1) CA2496712C (es)
CY (1) CY1109740T1 (es)
DE (1) DE602005017541D1 (es)
DK (1) DK1614687T3 (es)
EA (1) EA007743B1 (es)
EG (1) EG25619A (es)
ES (1) ES2336461T3 (es)
FR (1) FR2868775B1 (es)
GE (1) GEP20074136B (es)
HR (1) HRP20100024T1 (es)
MA (1) MA27598A1 (es)
MX (1) MXPA05003696A (es)
MY (1) MY140904A (es)
NO (1) NO329861B1 (es)
NZ (1) NZ538328A (es)
PL (1) PL1614687T3 (es)
PT (1) PT1614687E (es)
RS (1) RS51232B (es)
SG (1) SG116574A1 (es)
SI (1) SI1614687T1 (es)
UA (1) UA81773C2 (es)
WO (1) WO2005111027A1 (es)
ZA (1) ZA200501468B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
RU2473544C2 (ru) 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
CN102264689B (zh) 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
SI2902384T1 (en) 2010-02-12 2018-03-30 Krka, D.D., Novo Mesto The form of ivabradine hydrochloride
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
JP4515933B2 (ja) 2010-08-04
WO2005111027A1 (fr) 2005-11-24
CA2496712C (fr) 2010-04-06
ZA200501468B (en) 2005-11-30
EP1614687B1 (fr) 2009-11-11
CN100348585C (zh) 2007-11-14
ES2336461T3 (es) 2010-04-13
PL1614687T3 (pl) 2010-04-30
EA200500240A1 (ru) 2005-10-27
AU2005200884A1 (en) 2005-10-27
SI1614687T1 (sl) 2010-01-29
MY140904A (en) 2010-01-29
NO329861B1 (no) 2011-01-17
GEP20074136B (en) 2007-06-25
FR2868775B1 (fr) 2008-04-11
DK1614687T3 (da) 2010-03-29
HK1079777A1 (zh) 2006-04-13
NO20050888L (no) 2005-10-14
BRPI0500590B8 (pt) 2021-05-25
KR20060042117A (ko) 2006-05-12
NO20050888D0 (no) 2005-02-18
JP2010047577A (ja) 2010-03-04
DE602005017541D1 (de) 2009-12-24
CY1109740T1 (el) 2014-09-10
JP2005298478A (ja) 2005-10-27
RS51232B (sr) 2010-12-31
SG116574A1 (en) 2005-11-28
HRP20100024T1 (hr) 2010-02-28
AU2005200884B2 (en) 2010-07-15
CN1683343A (zh) 2005-10-19
US7064200B2 (en) 2006-06-20
EP1614687A1 (fr) 2006-01-11
CA2496712A1 (fr) 2005-10-13
US20050228178A1 (en) 2005-10-13
FR2868775A1 (fr) 2005-10-14
JP5277130B2 (ja) 2013-08-28
PT1614687E (pt) 2009-12-02
EA007743B1 (ru) 2006-12-29
ATE448221T1 (de) 2009-11-15
MXPA05003696A (es) 2006-01-24
EG25619A (en) 2012-03-26
UA81773C2 (uk) 2008-02-11
MA27598A1 (fr) 2005-11-01
BRPI0500590B1 (pt) 2018-10-09
KR100636499B1 (ko) 2006-10-18
BRPI0500590A (pt) 2005-11-16
NZ538328A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
AR047707A1 (es) Un procedimiento de sintesis de compuestos de la 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
Santi et al. Stereoselective selenium catalyzed dihydroxylation and hydroxymethoxylation of alkenes
Wei et al. New highly enantioselective thiourea-based bifunctional organocatalysts for nitro-Michael addition reactions
ATE480517T1 (de) Verfahren zur herstellung und reinigung von 2- hydrocarbyl-3,3-bis(4-hydroxyaryl-phthalimidin- monomeren
AR079491A1 (es) Metodos de sintesis de inhibidores del factor xa tal como el betrixaban y composiciones farmaceuticas que contienen la base libre de betrixaban o su sal sustancialmente pura.
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
CO5670092A1 (es) Nuevo proceso para la sintesis de ivabradina y sales de adi- cion de esta con un acido farmaceuticamente aceptable
Kanemitsu et al. A simple proline-based organocatalyst for the enantioselective reduction of imines using trichlorosilane as a reductant
Jia et al. Highly efficient prolinamide-based organocatalysts for the direct asymmetric aldol reaction in brine
AR049374A1 (es) Sintesis de compuestos de ester y acido borico
CO6640266A2 (es) Proceso para preparar derivados de dihidropirrol
PE20100051A1 (es) Nuevo procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-oa y aplicacion en la sintesis de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
Niu et al. One-pot transition-metal-free synthesis of Weinreb amides directly from carboxylic acids
AR048008A1 (es) Procesos para la preparacion de inhibidores de caspasa derivados de los mismos
Schwab et al. Organocatalytic asymmetric aldol reactions mediated by a cysteine-derived prolinamide
ATE530514T1 (de) Verfahren zur herstellung von alpha,beta- ungesättigten ethern
Abbastabar Ahangar et al. A one-pot synthesis of 1, 2-Dihydro-1-arylnaphtho [1, 2-e][1, 3] oxazine-3-one derivatives catalyzed by perchloric acid supported on silica (HClO4/SiO2) in the absence of solvent
Chen et al. Enantioselective Synthesis of Endocyclic β-Amino Acids with Two Contiguous Stereocenters via Hydrogenation of 3-Alkoxycarbonyl-2-Substituted Quinolines
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
AR064308A1 (es) Proceso de obtencion de cromanos, los mencionados compuestos, un intermediario para su sintesis, un metodo de sintesis de croman-3-il-dihidroimidazol-2-tiona que los emplea, un complejo de metales de transicion derivado de fosfin-bipiridina y su uso como catalizador.
Boyko et al. A stereoselective synthesis of asymmetrically substituted calix [4] arenecarbamates
Wang et al. Asymmetric synthesis of trifluoromethyl substituted dihydropyrans via organocatalytic cascade Michael–hemiketalization reaction
Xu et al. TMSCl-Promoted transition metal-catalyzed aza-Michael reactions of chalcones with carbamates
CN108059591A (zh) 一种手性α-氟-β-乙炔基酮化合物的催化不对称合成方法
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable

Legal Events

Date Code Title Description
FG Grant, registration